Clinical ink announces an exclusive perpetual license agreement with Observia to offer the SPURtm Adherence Solution for US patients with cardiometabolic disease, expanding our existing collaborations ...

CARsgen and Dispatch Bio ink clinical collaboration to evaluate flare platform and zevor-cel in solid tumours: Shanghai Wednesday, January 14, 2026, 18:00 Hrs [IST] CARsgen Therap ...

SciNeuro and Novartis ink licensing and collaboration agreement for next generation therapeutics to treat Alzheimer’s disease: Rockville, Maryland Tuesday, January 13, 2026, 15: ...

Biopharmaceutical company Rakuten announced the signing of a manufacturing partnership with contract development and ...

Theralase Technologies (USOTC:TLTFF) signed a clinical development agreement with Ferring Pharmaceuticals, a top name in ...

Eisai has reached a license agreement with Nuvation Bio, a global oncology company focused on tackling some of the toughest ...

Meanwhile, Novotech has appointed Anand Tharmaratnam as its own new CEO. Tharmaratnam has over 30 years of industry ...

This program covers a significant legal and political clash as the Supreme Court issues a notice to the West Bengal ...

On a Special Report, anchor Sonal Mehrotra Kapoor covers multiple national headlines, leading with the Brihanmumbai Municipal ...

Alphatec Holdings, Inc. , a provider of innovative solutions dedicated to revolutionizing spine surgery, and Theradaptive, Inc., a clinical-stage regenerative medicine company pioneering engineered ...

Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.

SBC Medical is in expansion mode, and its investment in OrangeTwist is the first step in that plan to make its mark in the ...